Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01312155
Other study ID # 10-338
Secondary ID
Status Completed
Phase N/A
First received March 8, 2011
Last updated October 24, 2013
Start date March 2011
Est. completion date February 2012

Study information

Verified date October 2013
Source McGill University Health Center
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Observational

Clinical Trial Summary

The study investigates assisted intubation using a videolaryngoscope in anesthesia.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date February 2012
Est. primary completion date February 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Easy airway assessment

Exclusion Criteria:

- Difficult airway

- ASA 3

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
Intubation
Intubation, endotracheal

Locations

Country Name City State
Canada MUHC Montreal Quebec

Sponsors (1)

Lead Sponsor Collaborator
McGill University Health Center

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Performance Success rate in % of intubation: Number of patients where 'assisted intubation' was successful 3 months No
Secondary Time Time to intubate: time in sec between insertion of scope into mouth and insertion of endotracheal tube through vocal cords 3 months No
See also
  Status Clinical Trial Phase
Completed NCT01571908 - Rapid Sequence Intubation With Magnesium-rocuronium Compared With Succinylcholine - A Randomised Clinical Study Phase 2
Completed NCT04921735 - An Observational Study of Cisatracurium 0.15 mg/kg in Young and Elderly (≥ 80 Years) Patients.
Completed NCT05476952 - Lean Body Weight-adjusted Rocuronium Dose and Intubation Conditions
Completed NCT04868409 - Intubating Conditions During Rapid Sequence Induction in Elderly With Either Suxamethonium 1.0 mg/kg or Rocuronium 1.0 mg/kg Phase 4